Attention Point Promotes ADHD Research by Offering DefiniPoint to Researchers at No Charge

Share Article

Attention Point®, a leading provider of online ADHD assessment tools, is pleased to announce it is offering DefiniPoint at no charge for clinical research.

“We want to help facilitate research on the assessment and treatment of ADHD,” stated Sam English, Ph.D., Founder and CEO of Attention Point. “By making DefiniPoint available for free to ADHD researchers, we hope to make data collection easier and accelerate the translation of research into clinical practice.”

Diagnosing ADHD is complicated and includes collecting behavioral observations from parents, teachers, and others (“observers”), generally through the use of standardized ADHD rating scales. Survey data show that even today, 80% of observers are still reporting this information via paper-and-pencil ADHD rating scales. The cumbersome nature of paper-and-pencil rating scales often leads to missing data, making it difficult to get all the information required to make the best informed diagnosis.

DefiniPoint® is the first and only complete online system that enables the efficient distribution, collection, and scoring of many well-accepted ADHD rating scales. DefiniPoint has been shown to increase the return rate and reduce the time it takes for Clinicians to receive these rating scales. Clinicians using DefiniPoint are seeing rating scales returned greater than 85% of the time and in less than 4 days.

“By using the Internet to connect parents, teachers, clients, and clinicians, DefiniPoint makes it easy for clinicians to gather behavioral information using standardized ADHD rating scales. This same efficiency should make it easier for researchers to gather the information they need to evaluate important treatment outcomes in their research” noted David Rabiner, Ph.D., clinical psychologist, professor, and Associate Dean at Duke University.

DefiniPoint offers many of the most popular ADHD diagnostic instruments currently available. These instruments have been used in more than 200 published research studies over the last 5 years. Since most of these studies utilized paper-based rating scales to gather multi-informant behavioral data, DefiniPoint can make it easier for researchers to use these instruments in future ADHD research. Among the rating scales available within DefiniPoint are the Vanderbilt ADHD Rating Scales and the Swanson, Nolan and Pelham (SNAP) Rating Scale, two of the most widely used rating scales in research on ADHD. The full list of available rating scales can be found at http://www.attentionpoint.com/definipoint_adhd_rating_scales.

About Attention Deficit Hyperactivity Disorder (ADHD)
ADHD is one of the most common childhood neurobehavioral disorders. According to the Centers for Disease Control and Prevention, parents report that approximately 11 percent or 6.4 million children ages 4 to 17 have been diagnosed with ADHD in the US and 82.5% of diagnosed children are receiving medication and/or treatment by a mental health professional.(1)

About DefiniPoint
DefiniPoint is the first and only complete online system that makes it easy and convenient to obtain needed ADHD behavioral information from multiple individuals. DefiniPoint enables clinicians to efficiently distribute, collect, and score many well-accepted ADHD rating scales for the evaluation and ongoing management of ADHD. For more information, visit http://www.DefiniPoint.com.

Notes To Editors
Attention Point is a health IT company dedicated to improving the diagnosis and management of neurobehavioral health disorders. We believe that technology can help Clinicians to more easily and accurately conduct ADHD assessments and provide better care for clients diagnosed with ADHD. We're committed to translating technology used in everyday life into user-friendly online tools that integrate seamlessly with clinical practice.

(1) http://www.cdc.gov/nchs/fastats/adhd.htm

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Sam English
Attention Point
+1 (877) 983-9998 Ext: 3
Email >
Visit website

Media